Atypical hemolytic uremic syndrome in a patient with protein-losing enteropathy

Ramy M. Hanna, Huma Hasnain, Lama Abdelnour, Beshoy Yanny, Richard Burwick

Research output: Contribution to journalArticle

Abstract

Atypical hemolytic uremic syndrome (aHUS) is an ultra-rare disease induced by many triggers, all of which produce a common end phenotype of microangiopathic hemolysis and thrombotic microangiopathy. We herein describe a 63-year-old woman with ongoing protein-losing enteropathy and frequent transudates caused by hypoalbuminemia. The patient was treated with eculizumab with a full hematologic and partial renal response. Protein-losing enteropathy is an inflammatory condition that has been linked with increased complement activation, which can trigger aHUS in patients with loss of CD55 expression. The patient in the present case had an increased estimated glomerular filtration rate but stage IV to V chronic kidney disease. One year later, she remains off dialysis with a stable estimated glomerular filtration rate. We herein report an unusual trigger of complement activation that in turn triggered aHUS in this patient.

Original languageEnglish (US)
Pages (from-to)4027-4032
Number of pages6
JournalJournal of International Medical Research
Volume47
Issue number8
DOIs
StatePublished - Aug 1 2019

Fingerprint

Protein-Losing Enteropathies
Chemical activation
Dialysis
Complement Activation
Glomerular Filtration Rate
Proteins
Thrombotic Microangiopathies
Hypoalbuminemia
Exudates and Transudates
Rare Diseases
Hemolysis
Chronic Renal Insufficiency
Phenotype
Kidney
Atypical Hemolytic Uremic Syndrome
eculizumab

Keywords

  • Atypical hemolytic uremic syndrome
  • eculizumab
  • hemolysis
  • hypoalbuminemia
  • protein-losing enteropathy
  • thrombotic microangiopathy

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Biochemistry, medical

Cite this

Atypical hemolytic uremic syndrome in a patient with protein-losing enteropathy. / Hanna, Ramy M.; Hasnain, Huma; Abdelnour, Lama; Yanny, Beshoy; Burwick, Richard.

In: Journal of International Medical Research, Vol. 47, No. 8, 01.08.2019, p. 4027-4032.

Research output: Contribution to journalArticle

Hanna, Ramy M. ; Hasnain, Huma ; Abdelnour, Lama ; Yanny, Beshoy ; Burwick, Richard. / Atypical hemolytic uremic syndrome in a patient with protein-losing enteropathy. In: Journal of International Medical Research. 2019 ; Vol. 47, No. 8. pp. 4027-4032.
@article{67775d18b5a347218f88706d2870b949,
title = "Atypical hemolytic uremic syndrome in a patient with protein-losing enteropathy",
abstract = "Atypical hemolytic uremic syndrome (aHUS) is an ultra-rare disease induced by many triggers, all of which produce a common end phenotype of microangiopathic hemolysis and thrombotic microangiopathy. We herein describe a 63-year-old woman with ongoing protein-losing enteropathy and frequent transudates caused by hypoalbuminemia. The patient was treated with eculizumab with a full hematologic and partial renal response. Protein-losing enteropathy is an inflammatory condition that has been linked with increased complement activation, which can trigger aHUS in patients with loss of CD55 expression. The patient in the present case had an increased estimated glomerular filtration rate but stage IV to V chronic kidney disease. One year later, she remains off dialysis with a stable estimated glomerular filtration rate. We herein report an unusual trigger of complement activation that in turn triggered aHUS in this patient.",
keywords = "Atypical hemolytic uremic syndrome, eculizumab, hemolysis, hypoalbuminemia, protein-losing enteropathy, thrombotic microangiopathy",
author = "Hanna, {Ramy M.} and Huma Hasnain and Lama Abdelnour and Beshoy Yanny and Richard Burwick",
year = "2019",
month = "8",
day = "1",
doi = "10.1177/0300060519864808",
language = "English (US)",
volume = "47",
pages = "4027--4032",
journal = "Journal of International Medical Research",
issn = "0300-0605",
publisher = "Field House Publishing LLP",
number = "8",

}

TY - JOUR

T1 - Atypical hemolytic uremic syndrome in a patient with protein-losing enteropathy

AU - Hanna, Ramy M.

AU - Hasnain, Huma

AU - Abdelnour, Lama

AU - Yanny, Beshoy

AU - Burwick, Richard

PY - 2019/8/1

Y1 - 2019/8/1

N2 - Atypical hemolytic uremic syndrome (aHUS) is an ultra-rare disease induced by many triggers, all of which produce a common end phenotype of microangiopathic hemolysis and thrombotic microangiopathy. We herein describe a 63-year-old woman with ongoing protein-losing enteropathy and frequent transudates caused by hypoalbuminemia. The patient was treated with eculizumab with a full hematologic and partial renal response. Protein-losing enteropathy is an inflammatory condition that has been linked with increased complement activation, which can trigger aHUS in patients with loss of CD55 expression. The patient in the present case had an increased estimated glomerular filtration rate but stage IV to V chronic kidney disease. One year later, she remains off dialysis with a stable estimated glomerular filtration rate. We herein report an unusual trigger of complement activation that in turn triggered aHUS in this patient.

AB - Atypical hemolytic uremic syndrome (aHUS) is an ultra-rare disease induced by many triggers, all of which produce a common end phenotype of microangiopathic hemolysis and thrombotic microangiopathy. We herein describe a 63-year-old woman with ongoing protein-losing enteropathy and frequent transudates caused by hypoalbuminemia. The patient was treated with eculizumab with a full hematologic and partial renal response. Protein-losing enteropathy is an inflammatory condition that has been linked with increased complement activation, which can trigger aHUS in patients with loss of CD55 expression. The patient in the present case had an increased estimated glomerular filtration rate but stage IV to V chronic kidney disease. One year later, she remains off dialysis with a stable estimated glomerular filtration rate. We herein report an unusual trigger of complement activation that in turn triggered aHUS in this patient.

KW - Atypical hemolytic uremic syndrome

KW - eculizumab

KW - hemolysis

KW - hypoalbuminemia

KW - protein-losing enteropathy

KW - thrombotic microangiopathy

UR - http://www.scopus.com/inward/record.url?scp=85071785509&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071785509&partnerID=8YFLogxK

U2 - 10.1177/0300060519864808

DO - 10.1177/0300060519864808

M3 - Article

VL - 47

SP - 4027

EP - 4032

JO - Journal of International Medical Research

JF - Journal of International Medical Research

SN - 0300-0605

IS - 8

ER -